| NCT ID | NCT07473089 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Insel Gruppe AG, University Hospital Bern |
| Condition | Joint (Knee or Hip Replacement) |
| Study Type | OBSERVATIONAL |
| Enrollment | 329 participants |
| Start Date | 2022-09-23 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 329 participants in total. It began in 2022-09-23 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study follows patients with infections after a joint replacement over time. During follow-up, treatment outcomes are carefully measured to determine whether the infection can be cured. In addition, factors that may change infection cure rates are examined, including the patient's overall health, the type of bacteria causing the infection, and the surgical and antibiotic treatments used. The goal is to understand what leads to more frequent cure and to improve future care.
Eligibility Criteria
Inclusion Criteria: * ≥18 years of age * Revision surgery of any large prosthetic joint (i.e., hip, knee, shoulder, ankle, or elbow) performed for a suspected or confirmed periprosthetic joint infections at any of the participating study centres. This includes patients who were previously treated at another hospital and referred to a participating study centre if data on a transferred patient from the previous institution are available, complete, and archived in the institutional patient information system, and the patient underwent at least one surgery at a participating institution. * Obtained written informed consent * Periprosthetic joint infections diagnosis likely or confirmed according to European Bone and Joint Infection Society criteria Exclusion Criteria: * Documented objection to subsequent use of personal health data * Patient follow-up outside of Switzerland * Diagnosis "periprosthetic joint infections unlikely" according to European Bone and Joint Infection Society criteria
Contact & Investigator
Nora Renz
PRINCIPAL INVESTIGATOR
Inselspital, Universitätsspital Bern
Frequently Asked Questions
Who can join the NCT07473089 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Joint (Knee or Hip Replacement). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07473089 currently recruiting?
Yes, NCT07473089 is actively recruiting participants. Contact the research team at nora.renz@insel.ch for enrollment information.
Where is the NCT07473089 trial being conducted?
This trial is being conducted at Aarau, Switzerland, Bern, Switzerland, Fribourg, Switzerland, Geneva, Switzerland and 1 additional location.
Who is sponsoring the NCT07473089 clinical trial?
NCT07473089 is sponsored by Insel Gruppe AG, University Hospital Bern. The principal investigator is Nora Renz at Inselspital, Universitätsspital Bern. The trial plans to enroll 329 participants.